Precision BioSciences Company Leadership

DTIL Stock  USD 13.56  0.58  4.47%   
Precision BioSciences' insiders are aggressively selling. The analysis of the overall insider sentiment regarding Precision BioSciences suggests that most insiders are panicking. Precision BioSciences employs about 115 people. The company is managed by 22 executives with a total tenure of roughly 16 years, averaging almost 0.0 years of service per executive, having 5.23 employees per reported executive.
Matthew Kane  CEO
CEO, Co-Founder

Precision BioSciences' Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-01-22Michael AmorosoDisposed 4579 @ 10.8View
2023-11-03Michael AmorosoDisposed 4167 @ 12View
2023-04-27Alan ListDisposed 259 @ 23.7View
Monitoring Precision BioSciences' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.

Precision BioSciences' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Precision BioSciences' future performance. Based on our forecasts, it is anticipated that Precision will maintain a workforce of about 200 employees by April 2024.
 
Covid

Precision BioSciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.2265) % which means that it has lost $0.2265 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5382) %, meaning that it created substantial loss on money invested by shareholders. Precision BioSciences' management efficiency ratios could be used to measure how well Precision BioSciences manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Capital Employed is expected to slide to -0.41. The value of Return On Assets is estimated to slide to -0.4. At this time, Precision BioSciences' Other Assets are quite stable compared to the past year. Non Currrent Assets Other is expected to rise to about 11.8 M this year, although the value of Net Tangible Assets will most likely fall to about 52.7 M.
The value of Common Stock Shares Outstanding is expected to slide to about 53.3 M. Net Loss is expected to rise to about (95.4 M) this year

Precision BioSciences Workforce Comparison

Precision BioSciences is one of the top stocks in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 432,907. Precision BioSciences adds roughly 115 in number of employees claiming only tiny portion of equities under Health Care industry.

Precision BioSciences Profit Margins

The company has Profit Margin (PM) of (1.41) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.94) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.94.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.510.58
Fairly Down
Slightly volatile

Precision BioSciences Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Precision BioSciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Precision BioSciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Precision BioSciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-03-01
0.5556
5
9
 577,782 
 785,985 
2023-12-01
0.6
3
5
 446,655 
 587,703 
2023-06-01
1.4
14
10
 878,607 
 143,289 
2023-03-01
2.125
17
8
 2,117,293 
 278,106 
2022-12-01
2.5
5
2
 1,613,908 
 35,214 
2022-09-01
0.2857
2
7
 45,237 
 252,088 
2022-06-01
1.0
9
9
 1,357,874 
 103,437 
2022-03-01
13.0
13
1
 1,277,599 
 21,514 
2021-06-01
1.075
43
40
 1,636,946 
 703,732 
2021-03-01
0.5128
20
39
 391,296 
 839,148 
2020-06-01
5.0
15
3
 1,098,895 
 18,444 
2020-03-01
2.0
4
2
 94,048 
 20,200 
2019-09-01
2.6667
8
3
 610,652 
 223,176 
2019-06-01
1.3636
15
11
 8,479,648 
 17,221,276 
2019-03-01
0.15
3
20
 34,544 
 2,150,735 

Precision BioSciences Notable Stakeholders

A Precision BioSciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Precision BioSciences often face trade-offs trying to please all of them. Precision BioSciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Precision BioSciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Matthew KaneCEO, Co-FounderProfile
Michael AmorosoCEO PresidentProfile
John RPhCFO OfficerProfile
Abid AnsariCFOProfile
Shalini SharpDirectorProfile
Drew ApplefieldDirector, Business DevelopmentProfile
Raymond SchinaziDirectorProfile
Mei BurrisDirector FinanceProfile
Maurissa MessierSenior CommunicationsProfile
Derek JantzChief CoFounderProfile
Jefferson SmithCoFounder OfficerProfile
Bruce StevensVice ComplianceProfile
John KellyChief OfficerProfile
Juli BlancheChief OfficerProfile
Garrett GincleyHead ManufacturingProfile
Christopher HeeryChief Medical OfficerProfile
Cindy AtwellChief OfficerProfile
Alan MDChief OfficerProfile
Heather KingDirector PRProfile
Jeyaraj AntonyResearch ScientistProfile
Shane BartonCo VPProfile
Dario ScimecaGeneral SecretaryProfile

About Precision BioSciences Management Performance

The success or failure of an entity such as Precision BioSciences often depends on how effective the management is. Precision BioSciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Precision management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Precision management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for 2024
Return On Capital Employed(0.39)(0.41)
Return On Assets(0.38)(0.40)
Return On Equity(3.25)(3.09)
The data published in Precision BioSciences' official financial statements usually reflect Precision BioSciences' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Precision BioSciences. For example, before you start analyzing numbers published by Precision accountants, it's critical to develop an understanding of what Precision BioSciences' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Precision BioSciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Precision BioSciences' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Precision BioSciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Precision BioSciences. Please utilize our Beneish M Score to check the likelihood of Precision BioSciences' management manipulating its earnings.

Precision BioSciences Workforce Analysis

Traditionally, organizations such as Precision BioSciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Precision BioSciences within its industry.

Precision BioSciences Manpower Efficiency

Return on Precision BioSciences Manpower

Revenue Per Employee454.7K
Revenue Per Executive2.4M
Net Loss Per Employee639.3K
Net Loss Per Executive3.3M
Working Capital Per Employee1.2M
Working Capital Per Executive6.3M
When determining whether Precision BioSciences is a strong investment it is important to analyze Precision BioSciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Precision BioSciences' future performance. For an informed investment choice regarding Precision Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Precision Stock analysis

When running Precision BioSciences' price analysis, check to measure Precision BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precision BioSciences is operating at the current time. Most of Precision BioSciences' value examination focuses on studying past and present price action to predict the probability of Precision BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precision BioSciences' price. Additionally, you may evaluate how the addition of Precision BioSciences to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Is Precision BioSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(25.76)
Revenue Per Share
13.887
Quarterly Revenue Growth
0.782
Return On Assets
(0.23)
Return On Equity
(1.54)
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.